|
|
||||||||
TECHNOLOGICAL ADVANCES IN PERITONEAL DIALYSIS RESEARCH |
Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong
Correspondence to: S. Yung, Department of Medicine, University of Hong Kong,
Queen Mary Hospital, Pokfulam Road, Hong Kong SAR,
China.
ssyyung{at}hkucc.hku.hk
The peritoneal mesothelium is composed of an extensive monolayer of
mesothelial cells that lines the body's serous cavity and internal organs and
was previously thought to act principally as a protective nonadhesive
lubricating surface to facilitate intracoelomic movement. With the
introduction of peritoneal dialysis over three decades ago, there has been
much interest in the cell biology of peritoneal mesothelial cells. Independent
studies have highlighted specific properties of the peritoneal mesothelial
cell, including antigen presentation, regenerative properties, clearance of
fibrin; synthesis of cytokines, growth factors, and matrix proteins; and
secretion of lubricants to protect the tissue from abrasion, adhesion,
infection, and tumor dissemination. It is now evident that the mesothelium is
not merely a passive membrane but, rather, a dynamic membrane that contributes
substantially to the structural, functional, and homeostatic properties of the
peritoneum. Since peritoneal mesothelial cells in culture possess
immunohistochemical markers identical to mesothelial stem cells, the culture
of mesothelial cells offers researchers an essential tool to assess their
morphologic, structural, and functional properties. This review will discuss
current procedures to isolate peritoneal mesothelial cells from human omental
specimens, animal sources, and spent dialysate. Furthermore, the functional
and morphologic properties of mesothelial cells are discussed, together with
the potential use of mesothelial cell culture in research and clinical
applications.
KEY WORDS: Peritoneal mesothelial cells; vimentin; cytokeratin; endothelial cells; peritoneal fibroblasts.
Received 21 July 2005; accepted 26 December 2005.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |